The closing price of Genesco Inc. (NYSE: GCO) was $20.19 for the day, down -32.18% from the previous closing price of $29.77. In other words, the price has decreased by -$9.58 from its previous closing price. On the day, 727038 shares were traded. GCO stock price reached its highest trading level at $23.15 during the session, while it also had its lowest trading level at $19.47.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Ratios:
Our analysis of GCO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.30 and its Current Ratio is at 1.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 02 when Bilunas Matthew M bought 510 shares for $49.01 per share. The transaction valued at 24,995 led to the insider holds 510 shares of the business.
Bojanowski Carolyn bought 510 shares of GCO for $24,995 on Feb 02. The Director now owns 510 shares after completing the transaction at $49.01 per share. On Sep 06, another insider, GEORGE THOMAS, who serves as the Sr VP-Finance and CFO of the company, bought 2,300 shares for $45.09 each. As a result, the insider paid 103,718 and bolstered with 29,036 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GCO now has a Market Capitalization of 253.65M and an Enterprise Value of 786.90M. As of this moment, Genesco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.45, and their Forward P/E ratio for the next fiscal year is 3.14. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.11 while its Price-to-Book (P/B) ratio in mrq is 0.40. Its current Enterprise Value per Revenue stands at 0.33 whereas that against EBITDA is 5.79.
Stock Price History:
Over the past 52 weeks, GCO has reached a high of $66.42, while it has fallen to a 52-week low of $29.18. The 50-Day Moving Average of the stock is 33.96, while the 200-Day Moving Average is calculated to be 43.88.
Shares Statistics:
GCO traded an average of 197.62K shares per day over the past three months and 267.61k shares per day over the past ten days. A total of 11.92M shares are outstanding, with a floating share count of 11.77M. Insiders hold about 5.70% of the company’s shares, while institutions hold 97.40% stake in the company. Shares short for GCO as of May 14, 2023 were 599.21k with a Short Ratio of 0.60M, compared to 486.07k on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.77% and a Short% of Float of 6.22%.
Earnings Estimates
The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$1.1 for the current quarter, with a high estimate of -$1.04 and a low estimate of -$1.16, while EPS last year was $0.44. The consensus estimate for the next quarter is $0.29, with high estimates of $0.42 and low estimates of $0.17.
Analysts are recommending an EPS of between $5.4 and $5.38 for the fiscal current year, implying an average EPS of $5.39. EPS for the following year is $6.44, with 2 analysts recommending between $6.5 and $6.38.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $482M to a low estimate of $474.01M. As of the current estimate, Genesco Inc.’s year-ago sales were $520.75M, an estimated decrease of -8.20% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $543.69M, an increase of 1.60% over than the figure of -$8.20% in the same quarter last year. There is a high estimate of $546M for the next quarter, whereas the lowest estimate is $541.38M.
A total of 2 analysts have provided revenue estimates for GCO’s current fiscal year. The highest revenue estimate was $2.41B, while the lowest revenue estimate was $2.4B, resulting in an average revenue estimate of $2.41B. In the same quarter a year ago, actual revenue was $2.38B, up 0.90% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $2.45B in the next fiscal year. The high estimate is $2.46B and the low estimate is $2.45B. The average revenue growth estimate for next year is up 1.90% from the average revenue estimate for this year.
